Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A 48-year-old man with colorectal liver metastases underwent insertion of an hepatic arterial infusion catheter for regional chemotherapy. Postoperative hepatic arterial perfusion scintigraphy showed that only part of the liver was being perfused by this route. Chemotherapy was administered weekly via the catheter. In effect, part of the liver received regional chemotherapy, whereas the remainder of the organ was exposed to systemic chemotherapy. Ultrasonography demonstrated shrinkage of the metastases in the area of liver receiving regional therapy, whereas disease progression occurred in the region of liver receiving 'systemic' treatment. This patient demonstrates that tumour may respond to regional chemotherapy despite disease progression on systemic therapy and suggests that a controlled trial would yield valuable data.

Type

Journal article

Journal

Eur J Surg Oncol

Publication Date

10/1990

Volume

16

Pages

464 - 467

Keywords

Chemotherapy, Cancer, Regional Perfusion, Fluorouracil, Hepatic Artery, Humans, Infusions, Intra-Arterial, Liver Neoplasms, Male, Middle Aged, Remission Induction, Sigmoid Neoplasms, Ultrasonography